In my previous ‘Hold’ rating on STERIS (NYSE: STE ) in September 2024, I expressed my concern about their overvalued stock price. Since then, the stock price has dropped by more than 10%, significantly underperforming the index (Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for ...